
2 new articles on DTC genetic testing (9/2/10)
See both links below. Both are from the new publication "Value-Based Cancer Care" (www.ValueBasedCancer.com)
New Tests, Genomic Information Change Physician Role available at http://www.valuebasedcancer.com/article/new-tests-genomic-information-change-physician-role?utm_source=Value-Based+Cancer+Care&utm_campaign=60dc83fa44-RSS_EMAIL_CAMPAIGN&utm_medium=email
A Little Genetic Information is a Dangerous Thing available at http://www.valuebasedcancer.com/article/little-genetic-information-dangerous-thing?utm_source=Value-Based+Cancer+Care&utm_campaign=60dc83fa44-RSS_EMAIL_CAMPAIGN&utm_medium=email upcoming webinar on cancer genomics on September 14th (8/31/10)
Cyber-Seminar Series > Genomics and Cancer Control: What to Know and What to Do
Tuesday, September 14, 2010, 2:003:00 p.m. ET
Seminar Summary
Genomics plays a role in nine of the ten leading causes of death in the United States, most notably cancer. Understanding how genes interact with environmental and behavioral risk factors, such as diet and physical activity, is central to cancer control and prevention efforts.
While the science of public health genomics continues to evolve, great strides in knowledge have been made. This interactive session will describe the science behind genomics and cancer control and prevention and illustrate practical strategies to incorporate genomic technology and genetic testing into public health programs.
The Centers for Disease Control and Prevention will explain the science behind public health genomics, describe new resources available to guide practitioners, and unveil new content available on Cancer Control P.L.A.N.E.T.
The Michigan Department of Community Health has sought creative ways to implement evidence-based public health genomics recommendations into their states health policy, education, and surveillance programs. Leaders from the department will speak about their experiences and lessons learned.
Learning Objectives:
At the end of the cyber-seminar, participants will be able to:
· Describe the evidence-base behind cancer genomics
· Identify available resources for evidence-based genomics recommendations
· Describe strategies used to implement evidence-based genomics in practice for cancer control and prevention
· Discuss lessons learned, successes, and ongoing challenges
register for the seminar on the Cancer Control Planet website: http://ccplanet.cancer.gov/cs_genomics.html .
Funding for Neuro-Oncology Nursing Research or rehabilitation nursing research (8/31/10)
Apply today for one of the $10,000 special grants through the 2011 ONS Foundation Small Grants Program
ONS Foundation/American Brain Tumor Association Neuro-Oncology Nursing Research Grant Designed to encourage nursing research in symptom management, support systems, or quality of life in people with brain tumors and their families. The PI must be actively involved in some aspect of neuro-oncology patient care, education, or research.
ONS Foundation/Rehabilitation Nursing Foundation Rehabilitation Nursing Research Grant
Designed to advance rehabilitation nursing in patients with cancer.
For all small grants, funding preference is given to projects that involve nurses in the design and conduct of the research activity and that promote theoretically based oncology practice. Membership in ONS is not required for eligibility. This $10,000 award is given at the beginning of the award period; the researcher has two years to complete the study.
Deadlines
Letters of intent are due September 1
Applications are due October 1
For more information and instructions, visit the ONS Foundation Website at:
Neuro-Oncology Research Grant: http://www.ons.org/Awards/FoundationAwards/NeuroOncology
Rehabilibation Research Grant: http://www.ons.org/Awards/FoundationAwards/Rehabilitation
check out GINAhelp.org (8/31/10)
GINAhelp.org is a site available that provides information on the Genetic Information Nondiscrimination Act. IOM Releases New Report - The Value of Genetic and Genomic Technologies (8/24/10)
The Roundtable on Translating Genomic-Based Research for Health is pleased to announce the release of their latest report.
The Value of Genetic and Genomic Technologies
Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice.
The report is available online as a free PDF. Hard copies will be available in October.
|